CYNTHIA ACOCK: Open Payments
NPI 1932816600 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 62 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $389 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $257 |
| ABBVIE INC. | 12 | $181 |
| Novo Nordisk Inc | 9 | $157 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Lundbeck LLC | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Tris Pharma Inc | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: REXULTI, Ozempic, FANAPT, AIRSUPRA, FARXIGA, QULIPTA, VRAYLAR, Auvelity.
Industry payments across TX — which companies pay providers there.
